As of early 2026, no peer-reviewed human clinical trials for BPC-157 have been published
The literatures were screened by entering the keywords like reactive oxygen species, ROS, free radical scavengers, generation of ROS, sources of ROS, antioxidants, antioxidant agents, oxidative stress, endogenous antioxidant, exogenous antioxidant, enzymatic antioxidant, non-enzymatic antioxidant, natural antioxidant, plant-derived antioxidant, role of ROS in cancer, role of ROS in diabetes, role of ROS in metabolic diseases, role of ROS in cardiovascular diseases, role of ROS in neurodegeneration
In 2004 he co-founded Sirtris Pharmaceuticals to develop drugs to treat age-associated diseases (acquired by GSK for $720M in 2008)
Sufficient levels of L-Carnitine are needed to oxidize fatty acids for energy, which is why many people believe that supplementing with l-carnitine is necessary to lose body fat
The great majority of BPC-157 research is preclinical, meaning animal and laboratory models rather than large human trials